You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

 

Online download statistics by month:

Online download statistics by month: August 2023 to June 2025

AbstractFullPdf
Aug 2023956961199
Sep 2023698699141
Oct 202334234356
Nov 202320520554
Dec 202318118254
Jan 202414614755
Feb 202410610643
Mar 202416616645
Apr 202413013157
May 202413614448
Jun 202411511638
Jul 202414414555
Aug 202411211128
Sep 2024707041
Oct 2024999941
Nov 202411011124
Dec 202411912029
Jan 202510710745
Feb 202511011230
Mar 2025858541
Apr 2025666617
May 2025959751
Jun 2025535327
Total435143761219